ACE2 and infection: Their in vitro studies provided evidence that this antimicrobial peptide can adhere to the binding domain of the main SARS-CoV-2 receptor, spike 1 protein, and simultaneously to the main host cell receptor, angiotensin-converting enzyme-2 (ACE2), thus decreasing viral adherence and protecting cells against pseudovirion infection [58].